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Background: This study aims to evaluate prospectively the incidence of stent fracture (SF) of Cypher stent (Cordis, J&J, Miami, Florida, US) and 
bare metal stents (BMS), and its clinical relevance if any, using fluoroscopic imaging.
Methods: Stent Boost fluoroscopy (Allura Xper FD10, Philips Medical Systems Netherlands) was conducted in a projection parallel to the long axis 
of the stent. Fractures were classified as single-strut (type I), incomplete transverse (type II), complete transverse without displacement (type III) 
and transverse with displacement (type IV). In case of possible SF detection by fluoroscopy, Intravascular Ultrasound (IVUS) and Optical Coherence 
Tomography (OCT) were performed.
Results: 138 patients with 200 Cypher stents (diameter 2.9±0.3mm, length 17.9±4.7mm) and 77 patients with 160 BMS (diameter 3.05±0.47, 
length 14.1±4) in native coronary lesions were studied at an interval of 46±16 months and 38.4±3.9 months post-implantation respectively. SF was 
indentified and subsequently verified with OCT in 6 cases (3%) of Cypher stents (4 type II, 1 type III and 1 type IV fracture), 5 located in the right 
coronary artery (3x18mm, 2.5x28mm, 3x33mm, 2.75x33mm, 3.5x18mm) and 1 in the left anterior descending artery (LAD, 2.5x18mm). All patients 
with SF were asymptomatic, although 4 Cypher stents (66.6%) demonstrated significant angiographic restenosis (≥50% luminal stenosis), and two 
(33.3%), needed re-intervention. SF type III was indentified and verified with IVUS and OCT in 1 case of BMS (0.63%) in the LAD (2.5x20mm), without 
angiographic restenosis. In all cases of SF the vascular segment of implantation demonstrated excessive angulation and repeated hinge motion 
during cardiac cycle on fluoroscopy and angiography. OCT and IVUS revealed altered stent geometry or/and lack of circumferential struts at the sites 
of interest.
Conclusions: Non-invasive fluoroscopic detection of SF is feasible and it reveals an incidence of Cypher fracture similar to that reported by 
invasive studies, in contrast to BMS, which have a much lower rate of SF. Cypher SF seems to be associated with a high rate of angiographic 
restenosis, however the clinical relevance of SF needs further evaluation.
